Home » Products » WEYERGANS VACUMED FLOW REGENERATION SYSTEM

WEYERGANS VACUMED FLOW REGENERATION SYSTEM

Intermittent vacuum therapy

Origin in space medicine
Vascular diseases are among the highest cost centres in the health care system. Incidences are rising and the quality of life of those affected continues to decline with increasing age.

The Intermittent vacuum therapy -IVT- has its technological origin in space medicine. In the absence of gravity (weightlessness), astronauts in space must undergo negative pressure application in an LBNPD (Lower Body Negative Pressure Device) every ten hours to avoid orthostatic complications due to an insufficient baroreflex; this is the only way to ensure sufficient blood flow in the periphery.
The further development of the LBNPD is the innovative VACUMED® Flow Regeneration System. The procedure was developed by Weyergans High Care AG together with the Institute of Space Medicine of the German Aerospace Center (DLR).
Category:

How Intermittent Vacuum Therapy – IVT – works

Like a second external heart

Intermittent vacuum therapy – IVT – alternately applies negative pressure (vacuum) and positive pressure to the lower extremities. This physiologically causes rhythmic vascular dilation and vascular compression, through that naturally provoking and the >>flow<< in a purely physical way.

The result: Blood circulation, capillarization and increase in venous and lymphatic reflux.

FOR MORE >> FLOW<< IN REHABILITATION AND IN THE TREATMENT OF VASCULAR DISEASES AND CHRONIC WOUNDS.

Overview of indications

INDICATION AIM OF USE ADDED VALUE
Fatigue-related pain-half muscle stiffness. Type 1 A. Pain reduction. Passive vascular training and intracorporeal lymphatic drainage promotion. Injury prophylaxis. Increase in performance; faster resumption of the next training session. Maintaining and being able to retrieve good training condition. Gold medal.
“Muscle soreness”, type 1B, DOMS. Recovery acceleration by rapid lactase and cK reduction after training or competition. Increase performance by reducing downtime.
Back-related neuromuscular muscle lesion.Type 2 A. Lumbar spine traction. Deblocking. Oedema and pain reduction. Intramuscular blood flow promotion and neuronal endothelial stimulation. Faster return to training or competition.
Muscle strain; neuromuscular muscle lesion.Type 2 B. Pain reduction. Lymphatic drainage and blood flow promotion. Faster stress build-up.
Muscle fibre tear (interfascicular) type 3 A Rapid pain and oedema reduction. Lymphatic drainage and blood circulation promotion. Reduce RTP (Return to Play) up to 40%.
Muscle bundle tear (interfascicular) type 3 B. Rapid acute pain and oedema reduction. Faster haematoma breakdown. Intramuscular wound healing promotion. Shortening of individual RTP between 30 to 50%.
(Sub-)total muscle tear. Avulsion. Sinewy avulsion. Type 4 Rapid acute pain and oedema reduction. Wound healing promotion and neural stimulation. Surgery avoidance. Shorten individual RTP by 30 to 50% while maintaining capillarisation and shortening recuperation time..
Post operative swelling conditions / Early post operative rehabilitation after radical surgery or knee / hip TEP in acute hospital. Lymphatic drainage, promotion of blood circulation and venous outflow. Oedema reduction. Rapid reduction of haematoma. Acceleration of wound healing. Tissue management. Early mobility promotion. Shortening of early rehabilitation (bloodless rapid discharge). Creates more capacity on ward and in theatre.
After amputations. Significantly faster and safer wound healing due to total flow promotion. Tissue management. Fast wound healing reduces risk of infection.
Neurological rehabilitation (Clinical Phase A – D) Active and passive mobilisation through flow promotion and neural stimulation. IVT helps to restore independence and quality of life (earlier).
Fibromyalgia Pain reduction, passive vascular training and neural stimulation. IVT makes the complaints manageable and increases the patient’s quality of life.
Rehabilitation after knee or hip TEP surgery. Pain relief, detonation and hyperaemia through passive vascular training. De-oedematisation. Mobility enhancement. Strengthening of physical resources and functions. Increase of endurance through capillarisation promotion (neuronal stimulation). IVT provides added value rehabilitation and faster everyday integration of the rehabilitant without additional staff burden.
Gonarthrosis (primary and secondary, unilateral or bilateral) De-oedema by lymphatic drainage. Maintenance or increase of capillarisation by neural stimulation. Traction. Pain relief and reduction of discomfort through passive ga-vascular training and hyperaemia. Optimising and accelerating the build-up and stabilisation phase while reducing the workload of the staff.
Polyneuropathy (peripheral) Intensive flow promotion (vascular training, blood flow promotion and lymphatic drainage) and neural stimulation for pain relief, prevention of muscle atrophy and spasms, reduction of RLS and paraesthesia. Maintenance of skin condition. Promote flow holistically, reduce symptomatology and improve quality of life with passive physical therapy. More USP for the medical facility.
Early geriatric rehabilitation (inpatient or outpatient) Physical therapy as part of complex treatment (in connection with pAVK, polyneuropathy or TEP), with a focus on passive vascular training (holistic flow promotion) and endothelial stimulation (capillarisation) to improve walking distance, reduce pain and increase vitality. IVT brings the geriatric rehabilitant back to his familiar self-determined environment sooner and faster.
Application of intermittent vacuum therapy (-IVT-) in arterial diseases
INDICATION AIM OF THE APPLICATION ADDED VALUE
pAVD I (Fontaine, ICD 170.20) Prevention of vascular sequelae by passive vascular training. Normalisation of the ABI. Avoiding the risks of heart attack or stroke and becoming vital old.
pAVD II (a and b, ICD 170.21 f) Prolongation of pain-free walking distance through passive vascular training and capillarisation. Increase in ABI. To be able to walk longer without pain through passive training.
pAVK III (ICD 170.23) Pain reduction and blood flow promotion; provocation of collateral formation. Improvement of ABI. Finally being able to sleep through and walk without pain again.
pAVK IV (gangrene, critical ischaemia, ICD 170.24 f) Revascularisation by stimulation of the endothelium (capillarisation and NO – release). Blood flow promotion (flow increase) and tissue oxygenation (tissue management). Quickly and effectively avoid amputation and reduce subsequent risks!
DFS (Diabetic Foot Syndrome) Wound healing promotion through capillarisation , NO – release and oxygenation. Tissue Mangement (M.O.I.S.T). Amputation risk down, quality of life up – through cost-effective IVT.
Application of intermittent vacuum therapy (-IVT-) for venous disorders
INDICATION AIM OF THE APPLICATION ADDED VALUE
CVI I (spider veins, reticular veins) Promotion of blood circulation and venous outflow by active vascular dilatation and compression. Improvement of the physiological muscle pump by increasing collagen synthesis. Oedema prophylaxis. Increase in positive body image of patients. Avoiding compression stockings. Avoiding sclerotherapy. Without the need for staff. Prevention of subsequent stages.
CVI II (CEAP 2, ICD-10 I83) varicose veins (varices). Active compression therapy. Venous outflow promotion. Increase of collagen synthesis and improvement of the physiological muscle pump. Venous return activation through active vein training. Optimisation of medical interventions (stripping, closures) through significant reduction of post op. rehabilitation time.
CVI III (CEAP 3) oedema due to venous insufficiency. Edema reduction (lymphatic drainage, perfusion and venous outflow promotion). Active compression therapy. With a holistic therapy approach with little effort, take the pressure off the extremity and achieve more patient well-being..
CVI III (CEAP 4 a and b, 5) skin lesions, eczema, dermato(lipo)sclerosis, athrophie blanche, healed venous ulcer. Skin regeneration and tissue management by optimising cellular metabolism and oxygenation. Reconvalesce damaged skin tissue through passive vascular training and restore skin health.
CVI III (CEAP 6, ICD-10 I83.0, ICD-10 I87.21) florid ulcer Granulation promotion and wound healing through tissue management, oxygenation and flow promotion. Bring chronic wounds to healing quickly. Game Change!
Use of IVT in oedema therapy
INDICATION AIM OF THE APPLICATION ADDED VALUE
Primary lymphoedema. Mechanical passive lymphatic drainage complementary or alternative to MLD. Very effective lymphatic drainage without personnel commitment. Invest once – benefit permanently (24/7). New perspectives in oedema therapy.
Secondary lymphoedema (post-operative acute phase) Mechanical passive lymphatic drainage complementary or alternative to MLD. Early rehabilitation leads to earlier discharge of the patient and thus increases the capacity and profitability of the facility.
Secondary lymphoedema (chronic) Mechanical passive lymphatic drainage complementary or alternative to MLD. Discharge of the department and staff with constant availability (24/7). Increase in therapeutic capacity.
Cellulite. Differentiated decongestive therapy leads to the removal of stored large-molecule metabolic residues, skin smoothing and optimisation of skin tone. Lucrative commercial application and prevention of subsequent leg conditions.
Lipoedema (all forms and stages). Mechanical passive lymphatic drainage complementary or alternative to MLD and compression. IVT opens up new business field study-based, simple, safe and profitable.
Post liposuction Mechanical passive lymphatic drainage complementary or alternative to MLD and compression. Shortening of rehabilitation and compression stocking wearing time. Fördert die USP der Einrichtung.
Combined lymphoedema / lipoedema, elephantiasis. Mechanical passive lymphatic drainage complementary or alternative to MLD and compression. Continuous availability of therapy increases the capacity of the facility and patient well-being without the need for staff.
Use of IVT in chronic wounds
INDICATION AIM OF THE APPLICATION ADDED VALUE
Extremities pressure ulcer. Mobilisation of the tissue through intensive holistic flow promotion (arterial, venous, lymphatic), exudate management and optimisation of the oxygen balance. Optimisation of skin care stabilises the patient and secures the hospital stay.
Arterial wounds (see also DFS and critical ischaemia). Holistic flow promotion (arterial, venous, lymphatic), capillarisation promotion and optimisation of the oxygen balance. Quick revascularisation avoids amputation.
Venous ulceration and mixtum. Mobilisation of tissue and rapid granulation and wound healing through intensive holistic flow promotion and enhancement of intradermal O2 – supply. Game Change: Wound healing instead of wound management also for long-term wounds in terms of patient well-being.

For the use of IVT in rehabilitation, you can find more information at www.vacusport.com.



• Duration of treatment: 25-40 minutes (depending on program and indication)
• Indication-specific treatment programs
• Class IIa medical device

Icon Vorteile Dollar

• Reduces DRG costs
• Compensation for nursing professionals
• Lucrative Billing Models
• Simple, secure and delegable

0`

• WxDxH: 2200 x 1200 x 1100 mm
• Device weight: 185 kg
• Mains voltage: 230 V / 50 – 650 Hz, 1.3000 VA
Other voltages possible:
• Suitable for patients up to 150 kg (185 kg*)
• *VACUMED® SL variant: With additional, electrical bed insert for non-mobile patients

Locations

This is where the IVT comes in:

Facilities for physical therapy
Practices for Vascular Medicine / Vascular Surgery
Diabetes centers
Wound care centers
Leg clinics
Orthopedics
Neurosurgery
Rehabilitation facilities
Sports medicine
Industrial medicine

Reviews

There are no reviews yet.

Be the first to review “WEYERGANS VACUMED FLOW REGENERATION SYSTEM”

Your email address will not be published. Required fields are marked *